Skip to main content
OpenTrials
Completed

NCT Number: NCT02118974

Randomized Clinical Trial Comparing Conventional Laparoscopic and Robot-Assisted Laparoscopic Hysterectomy

Robotic-assisted surgery is becoming more prominent within the specialty of Gynecologic surgery with little direct evidence that it is if not better than traditional laparoscopic surgery, at least equivalent. We designed a randomized-controlled trial to compare operative times, length of hospital stay, estimated blood loss, and post-operative complications associated with these two methods of minimally invasive hysterectomy.

Completed

Looking for future studies?

Notify Me

Key information

About this study

The proposed study will be a non-blinded randomized control trial. Patients will be randomized into each group Conventional Laparoscopic Hysterectomy (Group #1) and Robot-Assisted Laparoscopic Hysterectomy (Group #2) using a random number generator. Data collection will occur during the following points of patient interaction: pre-operative appointment, the surgical procedure, the patient's hospitalization, first post-operative appointment, and final post-operative appointment.

The care for the patients enrolled in this study will not deviate from the standard care of patients who are currently undergoing laparoscopic and robot-assisted laparoscopic hysterectomy. The patients who present to the office for pre-operative history and physical examination for laparoscopic hysterectomy will be counseled about participation in this study. Basic data collection will commence at the pre-operative visiting, including: patient demographics, past medical history, past surgical history, physical exam findings, and imaging results. The pre-operative appointment will occur between one to thirty days prior to surgery. Intra-operative and immediate post-operative data will be collected by the surgical assistant (resident or fellow) and will include surgical procedure (conventional laparoscopic or robot-assisted), operative time, hematocrit, estimated blood loss, length of stay, and complications.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Undergoing Hysterectomy
  • Able to consent to the procedure

Exclusion criteria

  • Medical conditions not allowing for pneumoperitoneum
  • Medical conditions not allowing proper ventilation during anesthesia
  • Pelvic organ prolapse amendable to a vaginal approach
  • Pregnant women
  • Patients undergoing planned combined procedures including bowel resection (other than coincidental appendectomy) or major urologic procedures.

Treatment and study plan

Hysterectomy

Procedure

Hysterectomy

Primary outcomes

  1. Operative Time

    Time frame: Intra operative

    The primary end point is difference in operative time

Secondary outcomes

  1. Complications

    Time frame: up to 6 weeks following intervention

    Complications related to the procedure including delays in discharge and re-admissions will be monitored and evaluated individually throughout the study.

Sponsors and collaborators

Lead sponsor

Milton S. Hershey Medical Center

Other

Registry information

Important dates

Study start
2014
Primary completion
2014
Study completion
2015
First posted
Apr 21, 2014
Registry last updated
Jan 20, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.